Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

The pharma sales rep: dodo or phoenix?

Ahead of its latest annual webinar on pharma promotional spending trends, IMS Health provides a snapshot of recent industry trends and the future for the sales rep. Apparently the model of the pharma sales rep is on its last legs, as pharma companies continue more and more rounds of layoffs, removing the last…

Articles

What does evolutionary theory predict for the future of the ...

We speak with Professor Brian D Smith who shares his thoughts on how Darwin’s theory of evolution can be applied to pharma marketing. This month on pharmaphorum, we’ve invited top experts within the marketing sector to share their thoughts on...

Articles

Pharma sales part two – the complete picture

As the pharma sales approach faces continued downsizing and adaptation, Marie Crespo explores how you can hang onto your key sales people in times of change. There was a time during the so-called Sales Wars of a few years ago that it might have been legitimate to say: ‘May the sales force be with you!’ At the time, rival sales forces were…

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital